TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the…
Compass to Host Investor Event on Monday, January 23rd at 8:30am ET CTX-009 in combination with paclitaxel demonstrated a 37.5% overall response rate (ORR) in 24 patients with BTC treated…
Three abstracts highlight the safety and efficacy of briquilimab combined with low-toxicity radiation conditioning to achieve full donor engraftment and leukemia disease eradication Data…
Aishwarya Vidhya Raghunath presenting her concert for Naada Inbam, in December 2022.
| Photo Credit: Special Arrangement
Expanding upon her opening kriti for 24 minutes, Aishwarya Vidhya…
MORRISTOWN, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel…
FORT MYERS, Fla., Dec. 14, 2022 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) is pleased to announce that seven research studies co-authored by AON physicians were presented at…
The Constitutional Court on Friday extended the suspension of its own finding on the invalidity of the country’s Electoral Act to 31 January 2023 – and must now also deal with an…
Oral podium presentation highlights data demonstrating a 79% overall response rate and complete responses in 43% of relapsed or refractory CD30-positive lymphomas treated with Tessa’s “off…